19th week of 2018 patent applcation highlights part 9 |
Patent application number | Title | Published |
20180125790 | Sustained Release Aminopyridine Composition | 2018-05-10 |
20180125791 | POLYMER NANOCAPSULES FOR PROTEIN DELIVERY | 2018-05-10 |
20180125792 | NON-STEROIDAL ANTI-INFLAMMATORY DRUGS FOR COUGH | 2018-05-10 |
20180125793 | COMPOSITIONS AND METHODS FOR THE REMOVAL OF EAR WAX | 2018-05-10 |
20180125794 | Induced Expression of Brain Derived Neurotrophic Factor (BDNF) for Treatment of Neuromuscular, Neurodegenerative, Autoimmune, Developmental and/or Metabolic Diseases | 2018-05-10 |
20180125795 | CINNAMALDEHYDE COMPOSITIONS AND METHODS | 2018-05-10 |
20180125796 | TREATMENT OF MYCOBACTERIAL INFECTION | 2018-05-10 |
20180125797 | METHODS FOR TREATING SKIN DISORDERS WITH A TOPICAL COMPOSITION OF BIS-(2-CHLOROETHYL)METHYLAMINE | 2018-05-10 |
20180125798 | Compounds and Methods for Modulating Serotonin Receptors in the Periphery | 2018-05-10 |
20180125799 | THERAPY FOR LEUKEMIA | 2018-05-10 |
20180125800 | Stable Formulation for Parenteral Administration of Tapentadol | 2018-05-10 |
20180125801 | METHODS FOR SELECTING PHOSPHATASE SELECTIVE AND NON-SELECTIVE PHOSPHATASE INHIBITORS | 2018-05-10 |
20180125802 | SOLID-FORMING TOPICAL FORMULATIONS FOR PAIN CONTROL | 2018-05-10 |
20180125803 | METHODS OF INHIBITING PAIN | 2018-05-10 |
20180125804 | SYNERGISTIC FAMCICLOVIR AND CELECOXIB COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES | 2018-05-10 |
20180125805 | PROPHYLACTIC/THERAPEUTIC AGENT FOR VIRUS INFECTIONS WHICH COMPRISES ALA COMPOUND | 2018-05-10 |
20180125806 | NITRATED-FATTY ACIDS MODULATION OF TYPE II DIABETES | 2018-05-10 |
20180125807 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND/OR PAIN | 2018-05-10 |
20180125808 | BIOFILM INHIBITING COMPOSITIONS ENHANCING WEIGHT GAIN IN LIVESTOCK | 2018-05-10 |
20180125809 | Methods Of Using Low-Dose Doxepin For The Improvement Of Sleep | 2018-05-10 |
20180125810 | NOVEL ANTITUMORAL USE OF CABAZITAXEL | 2018-05-10 |
20180125811 | 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof | 2018-05-10 |
20180125812 | Dehydroacetic Acid (DHAA) and Derivative for Uses in Treating Cancer | 2018-05-10 |
20180125813 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2018-05-10 |
20180125814 | CANCER TREATMENT METHOD USING AILANTHONE COMPOUNDS | 2018-05-10 |
20180125815 | CDC7 KINASE INHIBITORS AND USES THEREOF | 2018-05-10 |
20180125816 | SAROGLITAZAR MAGNESIUM FOR THE TREATMENT OF CHYLOMICRONEMIA SYNDROME | 2018-05-10 |
20180125817 | COMBINATIONS COMPRISING A PYRROLIDINE-2,5-DIONE IDO1 INHIBITOR AND AN ANTI-BODY | 2018-05-10 |
20180125818 | METHODS AND COMPOSITIONS FOR TREATING SCHIZOPHRENIA | 2018-05-10 |
20180125819 | AMORPHOUS TECOVIRIMAT PREPARATION | 2018-05-10 |
20180125820 | SACUBITRIL-VALSARTAN DOSAGE REGIMEN FOR TREATING HEART FAILURE | 2018-05-10 |
20180125821 | TAU-PROTEIN TARGETING PROTACS AND ASSOCIATED METHODS OF USE | 2018-05-10 |
20180125822 | TREATMENT USING DANTROLENE | 2018-05-10 |
20180125823 | IMIDAZOLE DERIVATIVES | 2018-05-10 |
20180125824 | LIQUID FORMULATIONS OF BENDAMUSTINE | 2018-05-10 |
20180125825 | BIOTIN FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | 2018-05-10 |
20180125826 | SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2018-05-10 |
20180125827 | 5-DEUTERO-THIAZOLIDINE-2,4-DIONE COMPOUNDS AND METHODS OF TREATING MEDICAL DISORDERS USING SAME | 2018-05-10 |
20180125828 | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PULMONARY HYPERTENSION | 2018-05-10 |
20180125829 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS | 2018-05-10 |
20180125830 | MICROBICIDAL COMPOSITION COMPRISING AN OCTOXYNOL AND A QUINOLIZIDINE ALKALOID COMPOUND OR A SOURCE THEREOF | 2018-05-10 |
20180125831 | COMBINATION THERAPIES FOR TREATING CANCER | 2018-05-10 |
20180125832 | USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATED LIVER CANCER | 2018-05-10 |
20180125833 | METHOD FOR PREVENTING LUNG DISEASES IN SMOKERS AND NON-SMOKERS USING ANTIHYPERTENSIVE DRUG | 2018-05-10 |
20180125834 | METHODS OF TREATING BACTERIAL INFECTIONS AND FUNGAL INFECTIONS USING ENANTIOPURE DEUTERIUM-ENRICHED PIOGLITAZONE | 2018-05-10 |
20180125835 | Dosage and Use of an A2A Antagonist | 2018-05-10 |
20180125836 | METHOD FOR INHIBITING PLATELET AGGREGATION | 2018-05-10 |
20180125837 | COMPOSITIONS AND METHODS FOR TREATMENT RELATED TO FALL AND FALL FREQUENCY IN NEURODEGENERATIVE DISEASES | 2018-05-10 |
20180125838 | METHODS OF TREATMENT WITH DEUTERATED CFTR POTENTIATORS | 2018-05-10 |
20180125839 | METHOD OF INHIBITING MUTANT C-KIT | 2018-05-10 |
20180125840 | TREATMENT OF PRURIGO NODULARIS | 2018-05-10 |
20180125841 | KETOCONAZOLE ENANTIOMER IN HUMANS | 2018-05-10 |
20180125842 | Ergoloid for Cancer | 2018-05-10 |
20180125843 | Method Of Treating Metabolic Disorders And Depression With Dopamine Receptor Agonists | 2018-05-10 |
20180125844 | TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS | 2018-05-10 |
20180125845 | Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders | 2018-05-10 |
20180125846 | Targeted Therapies for Cancer | 2018-05-10 |
20180125847 | METHODS FOR TREATMENT OF RETINAL DISEASE BY PHOTORECEPTOR GENE EXPRESSION MODULATION | 2018-05-10 |
20180125848 | PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS | 2018-05-10 |
20180125849 | PYRAZOLO [3,4-D] PYRIMIDINE DERIVATIVES USEFUL TO TREAT RESPIRATORY DISORDERS | 2018-05-10 |
20180125850 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | 2018-05-10 |
20180125851 | METHODS FOR TREATING PULMONARY HYPERTENSION | 2018-05-10 |
20180125852 | COMPOSITIONS AND METHODS FOR TREATMENT OF GLIOMA | 2018-05-10 |
20180125853 | OXAZINE DERIVATIVE FOR USE IN THE TREATMENT OR PREVENTION OF CEREBRAL AMYLOID ANGIOPATHY | 2018-05-10 |
20180125854 | THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME | 2018-05-10 |
20180125855 | SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY | 2018-05-10 |
20180125856 | USE OF GLUCOCORTICOID RECEPTOR ANTAGONIST AND SOMATOSTATIN ANALOGUES TO TREAT ACTH-SECRETING TUMORS | 2018-05-10 |
20180125857 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2018-05-10 |
20180125858 | BIOAVAILABLE SOLID STATE (17- β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS | 2018-05-10 |
20180125859 | Methods for Inhibiting the Development of Huntington's Disease | 2018-05-10 |
20180125860 | Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects | 2018-05-10 |
20180125861 | OCULAR THERAPY USING GLUCOCORTICOID DERIVATIVES SELECTIVELY PENETRATING POSTERIOR SEGMENT TISSUES | 2018-05-10 |
20180125862 | TREATMENT FOR HEPATIC FIBROSIS | 2018-05-10 |
20180125863 | ABIRATERONE ACETATE LIPID FORMULATIONS | 2018-05-10 |
20180125864 | A METHOD FOR SCREENING REGULATOR OF MITOCHONDRIAL FISSION | 2018-05-10 |
20180125865 | WITHAFERIN COMPOSITIONS FOR PREVENTION OF AGING | 2018-05-10 |
20180125866 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2018-05-10 |
20180125867 | COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS | 2018-05-10 |
20180125868 | CONNECTIVE TISSUE MONITORING, COMPOSITIONS FOR CONNECTIVE TISSUE TREATMENT AND METHODS FOR TREATING CONNECTIVE TISSUE | 2018-05-10 |
20180125869 | BISPHOSPHONATE COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE | 2018-05-10 |
20180125870 | COMPOSITIONS, METHODS OF TREATMENT AND DIAGNOSTICS FOR TREATMENT OF HEPATIC STEATOSIS ALONE OR IN COMBINATION WITH A HEPATITIS C VIRUS INFECTION | 2018-05-10 |
20180125871 | Targeting NAD+ to Treat Chemotherapy and Radiotherapy Induced Cognitive Impairment, Neuropathies and Inactivity | 2018-05-10 |
20180125872 | FIXED-DOSE PHARMACEUTICAL COMPOSITION COMPRISING RIFABUTIN, CLARITHROMYCIN, AND CLOFAZIMINE | 2018-05-10 |
20180125873 | ANALOGUES OF ETOPOSIDE FOR THE TREATMENT OF TUMOURS | 2018-05-10 |
20180125874 | Compositions and Methods to Accelerate Resolution of Acute Lung Inflammation | 2018-05-10 |
20180125875 | SYNERGISTIC ENHANCEMENT OF 5-FLUOROURACIL CYTOTOXICITY BY DEOXYURIDINE ANALOGS IN CANCER CELLS | 2018-05-10 |
20180125876 | Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages | 2018-05-10 |
20180125877 | IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT | 2018-05-10 |
20180125878 | CONTINUOUSLY EXPRESSED THERAPEUTIC RNAS FOR TARGETED PROTEIN BINDING AND METHODS FOR THEIR USE | 2018-05-10 |
20180125879 | Use of Polysaccharide for Treating ST-Elevation Myocardial Infarction and Diseases of the Digestion System | 2018-05-10 |
20180125880 | COMPOSITION FOR TREATING TISSUE LESIONS | 2018-05-10 |
20180125881 | LINEAR POLYOL STABILIZED POLYFLUOROACRYLATE COMPOSITIONS | 2018-05-10 |
20180125882 | Compositions And Methods For Treating Diseases Or Disorders Using Extended Release Nitric Oxide Releasing Solutions | 2018-05-10 |
20180125883 | INHALATION OF NITRIC OXIDE FOR TREATING RESPIRATORY DISEASES | 2018-05-10 |
20180125884 | MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA | 2018-05-10 |
20180125885 | COMPOSITIONS COMPRISING CINNAMALDEHYDE AND ZINC AND METHODS OF USING SUCH COMPOSITIONS | 2018-05-10 |
20180125886 | HIGH-PERFORMANCE ADSORBENTS BASED ON ACTIVATED CARBON HAVING HIGH MESO- AND MACROPOROSITY | 2018-05-10 |
20180125887 | ANTI-INFLAMMATORY AGENTS | 2018-05-10 |
20180125888 | Methods and Compositions High Scale Therapeutic Production of Memory NK Cells | 2018-05-10 |
20180125889 | MODIFIED GAMMA DELTA T CELLS AND USES THEREOF | 2018-05-10 |